Endo International PLC
NASDAQ:ENDP
Endo International PLC
Cash from Operating Activities
Endo International PLC
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Endo International PLC
NASDAQ:ENDP
|
Cash from Operating Activities
$269.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Perrigo Company PLC
NYSE:PRGO
|
Cash from Operating Activities
$405.5m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-3%
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
Cash from Operating Activities
$1.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
14%
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Cash from Operating Activities
-$128.5m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-20%
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
Cash from Operating Activities
-$33.3m
|
CAGR 3-Years
-366%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
Cash from Operating Activities
€33.6m
|
CAGR 3-Years
37%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
15%
|
See Also
What is Endo International PLC's Cash from Operating Activities?
Cash from Operating Activities
269.2m
USD
Based on the financial report for Dec 31, 2022, Endo International PLC's Cash from Operating Activities amounts to 269.2m USD.
What is Endo International PLC's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 1Y
-35%
Over the last year, the Cash from Operating Activities growth was -35%.